| 801 |
10589764 | TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer. | 1999 Nov |
1 |
| 802 |
10615232 | Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. | 1999 Aug |
1 |
| 803 |
10626356 | Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance. | 1999 Oct |
2 |
| 804 |
10632346 | Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. | 1999 Dec |
1 |
| 805 |
10665656 | Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. | 1999 Dec |
3 |
| 806 |
10674873 | Mdm2 sensitizes MCF7 breast cancer cells to cisplatin or carboplatin. | 1999 Nov |
3 |
| 807 |
10697522 | De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. | 1999 Nov-Dec |
6 |
| 808 |
9455805 | Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. | 1998 Jan 30 |
1 |
| 809 |
9458352 | Role of p53 and apoptosis in sensitization of cis-diamminedichloroplatinum antitumor activity by interleukin-1 in ovarian carcinoma cells. | 1998 Feb |
3 |
| 810 |
9474928 | [Molecular therapy for human cancer with tumor suppressor p53 gene transfer]. | 1998 Jan |
1 |
| 811 |
9485023 | Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. | 1998 Feb 15 |
7 |
| 812 |
9498829 | In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer. | 1998 Jan |
1 |
| 813 |
9506540 | Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. | 1998 Mar 16 |
1 |
| 814 |
9508372 | Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. | 1998 Feb |
2 |
| 815 |
9548450 | Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas. | 1998 Feb |
1 |
| 816 |
9584207 | Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. | 1998 May |
3 |
| 817 |
9607592 | Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. | 1998 May |
1 |
| 818 |
9619834 | mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. | 1998 Apr 30 |
1 |
| 819 |
9620551 | Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. | 1998 May 7 |
2 |
| 820 |
9635829 | Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. | 1998 May |
4 |
| 821 |
9636834 | Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol. | 1998 Apr |
1 |
| 822 |
9652752 | Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. | 1998 May |
1 |
| 823 |
9664115 | The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. | 1998 Aug |
1 |
| 824 |
9681825 | Mutant p53 protein expression interferes with p53-independent apoptotic pathways. | 1998 Jun 25 |
1 |
| 825 |
9698467 | Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II). | 1998 Jul |
5 |
| 826 |
9700726 | DNA binding activities of p53 protein following cisplatin damage of ovarian cells. | 1998 |
8 |
| 827 |
9703286 | Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status. | 1998 Aug |
2 |
| 828 |
9713515 | Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer. | 1998 Jul-Aug |
1 |
| 829 |
9713990 | Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system. | 1998 Sep |
2 |
| 830 |
9731490 | Ionizing radiation inhibits chemotherapy-induced apoptosis in cultured glioma cells: implications for combined modality therapy. | 1998 Sep 1 |
2 |
| 831 |
9772293 | Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs. | 1998 Nov |
1 |
| 832 |
9788435 | Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs. | 1998 Oct 15 |
1 |
| 833 |
9811465 | Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity. | 1998 Nov 5 |
10 |
| 834 |
9837785 | Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation. | 1998 Nov 25 |
1 |
| 835 |
9893672 | A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells. | 1998 Oct |
3 |
| 836 |
9951689 | Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry. | 1998 Dec |
1 |
| 837 |
10081494 | EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway. | 1998 Dec |
2 |
| 838 |
9010220 | Identification of p53 genetic suppressor elements which confer resistance to cisplatin. | 1997 Jan 16 |
4 |
| 839 |
9013707 | The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity. | 1997 Jan 10 |
4 |
| 840 |
9174048 | Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. | 1997 May 8 |
3 |
| 841 |
9186003 | Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. | 1997 Jun |
1 |
| 842 |
9212237 | Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53. | 1997 Jul 3 |
5 |
| 843 |
9291435 | mdm 2 mRNA expression is associated with survival in ovarian cancer. | 1997 Aug 22 |
3 |
| 844 |
9312058 | Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53. | 1997 Oct 1 |
1 |
| 845 |
9323493 | Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis. | 1997 |
4 |
| 846 |
9359484 | Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent. | 1997 Nov 4 |
1 |
| 847 |
9374378 | Reduced expression of the ICE-related protease CPP32 is associated with radiation-induced cisplatin resistance in HeLa cells. | 1997 |
1 |
| 848 |
9389577 | Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines. | 1997 Nov 14 |
2 |
| 849 |
9403032 | Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. | 1997 Nov 19 |
1 |
| 850 |
9413185 | Mechanism of apoptosis induced by cisplatin and VP-16 in PANC-1 cells. | 1997 Sep-Oct |
1 |